Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's skin condition, diagnosed as contact dermatitis, has been rated at a noncompensable level since February 11, 2006. However, the Board found that intermittent systemic therapy such as corticosteroids was required for less than six weeks during any twelve-month period on appeal, warranting a 10 percent rating.

The deciding factor: The Veteran's skin condition has required intermittent systemic therapy (corticosteroids) but not to a degree that would warrant a higher rating under the criteria for Diagnostic Code 7806.

Claimed conditions
contact dermatitis (skin disability)
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
March 5, 2013
Citation
1307436

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1307436.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.